These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8583377)

  • 1. Endothelin-1-induced endothelin-1 release causes cerebral vasospasm in-vivo.
    Zuccarello M; Romano A; Passalacqua M; Rapoport RM
    J Pharm Pharmacol; 1995 Aug; 47(8):702. PubMed ID: 8583377
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
    Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
    Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.
    Zuccarello M; Boccaletti R; Romano A; Rapoport RM
    Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endothelin in experimental cerebral vasospasm.
    Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
    Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelins activate phospholipase A2 in brain capillary endothelial cells.
    Vigne P; Frelin C
    Brain Res; 1994 Jul; 651(1-2):342-4. PubMed ID: 7922585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration by Iloprost of the vasospastic effects of endothelin-1 in rabbit cerebral vessels.
    Keskil IS; Baykaner MK; Sencer H; Ataoğlu O; Ilgit E; Erdoğan B; Ceviker N; Ercan ZS
    Neuroreport; 1994 May; 5(9):1089-92. PubMed ID: 7521681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?
    Cosentino F; Katusić ZS
    Stroke; 1994 Apr; 25(4):904-8. PubMed ID: 8160238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model.
    Itoh S; Sasaki T; Asai A; Kuchino Y
    J Neurosurg; 1994 Nov; 81(5):759-64. PubMed ID: 7931624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats.
    Jośko J; Hendryk S; Jedrzejowska-Szypułka H; Słowiński J; Gwóźdź B; Lange D; Harabin-Słowińska M
    J Physiol Pharmacol; 2000 Jun; 51(2):241-9. PubMed ID: 10898097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists.
    Zuccarello M; Soattin GB; Lewis AI; Breu V; Hallak H; Rapoport RM
    J Neurosurg; 1996 Mar; 84(3):503-7. PubMed ID: 8609565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
    Zimmermann M; Seifert V
    Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin on the canine basilar artery.
    Kobayashi H; Hayashi M; Kobayashi S; Kabuto M; Handa Y; Kawano H
    Neurosurgery; 1990 Sep; 27(3):357-61. PubMed ID: 2234327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.
    Nirei H; Hamada K; Shoubo M; Sogabe K; Notsu Y; Ono T
    Life Sci; 1993; 52(23):1869-74. PubMed ID: 8318117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.
    Clozel M; Watanabe H
    Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 of canine basilar artery in vasospasm.
    Yamaura I; Tani E; Maeda Y; Minami N; Shindo H
    J Neurosurg; 1992 Jan; 76(1):99-105. PubMed ID: 1727175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.